Leu(31)-Pro(34)- neuropeptide Y (NY-LP)

Subscribe to Selected New Research on Leu(31)-Pro(34)- neuropeptide Y

1 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: specific Y1 receptor agonist

Also Known As:

NY-LP; neuropeptide Y, Leu(31)-Pro(34)-; (Leu(31),Pro(34))NPY; 31-Leu-34-Pro-neuropeptide Y; NPY(Leu(31),Pro(34)); neuropeptide Y, leucyl(31)-proline(34)-

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins

Proteins: 56522

Nerve Tissue Proteins: 2

Neuropeptides: 3367

Neuropeptide Y: 1581

Leu(31)-Pro(34)- neuropeptide Y: 1

Peptides: 16074

Neuropeptides: 3367

Neuropeptide Y: 1581

Leu(31)-Pro(34)- neuropeptide Y: 1

Related Diseases

1.	Stroke (Strokes) 04/15/2002 - "In a rat endovascular middle cerebral artery occlusion (MCAO) stroke model, we previously showed that intracerebroventricular (ICV) injection of neuropeptide Y (NPY) or an Y1 receptor agonist, [Leu(31),Pro(34)]-NPY, increased the infarct volume, that an Y1 receptor antagonist, BIBP3226, reduced the infarct volume, and that an Y2 receptor agonist, NPY3-36, had no effect" Get all the results and reference details, order at left...
2.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/15/2002 - "In a rat endovascular middle cerebral artery occlusion (MCAO) stroke model, we previously showed that intracerebroventricular (ICV) injection of neuropeptide Y (NPY) or an Y1 receptor agonist, [Leu(31),Pro(34)]-NPY, increased the infarct volume, that an Y1 receptor antagonist, BIBP3226, reduced the infarct volume, and that an Y2 receptor agonist, NPY3-36, had no effect" Get all the results and reference details, order at left...
2 Diseases and 1 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Neuropeptide Y
2.	BIBP 3226
2 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>